Luminoma Diagnostics
PrivateLast Round
Series A
Jul 1, 2026
Total Funding Raised
$8.82M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Luminoma Diagnostics operates in Healthcare & Life Sciences and is based in Auckland. Its latest recorded funding round was a Seed round in December 2025.
Luminoma Diagnostics is a diagnostic equipment company that develops a portable, non-invasive device using Raman spectroscopy and machine learning to aid clinicians in the early detection of skin cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luminoma Diagnostics Comparables
Compare Luminoma Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GRAIL | 70% | |
| Guardant Health | 67% | |
| DermTech, LLC | 59% |
For institutional investors. Book with your work email.
Luminoma Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2026 | ||||
| Seed | Dec 8, 2025 | ||||
| Crowdfunding | Aug 13, 2025 | ||||
| Seed | Jun 6, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Luminoma Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalist Nominee Limited | Crowdfunding |
| Bridgewest Ventures | Crowdfunding, Seed |
| Angel HQ | Seed |
| Pacific Channel | Crowdfunding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 156% MoM, reaching 1.1K.
- Jul 25, 2026
Monthly visitors increased 142% MoM, reaching 416.
For institutional investors. Book with your work email.
Luminoma Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Luminoma Diagnostics's valuation, stock price, and market status.
Is Luminoma Diagnostics a public or private company?
Luminoma Diagnostics is a private company.
What is the current stock price of Luminoma Diagnostics?
Luminoma Diagnostics is a private company, so its shares have no public market price. Caplight tracks Luminoma Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Luminoma Diagnostics worth (valuation)?
Valuation information for Luminoma Diagnostics is not publicly available.
Can I buy Luminoma Diagnostics stock?
Luminoma Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Luminoma Diagnostics's last funding round?
Luminoma Diagnostics's most recent funding round was Series A on July 1, 2026.
Who are the main investors in Luminoma Diagnostics?
Key investors in Luminoma Diagnostics include Catalist Nominee Limited, Bridgewest Ventures, Angel HQ, Pacific Channel.
Will Luminoma Diagnostics IPO soon?
No public IPO plans have been announced for Luminoma Diagnostics.
How can I track Luminoma Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Luminoma Diagnostics's shares on secondary markets.